38. "Opdivo was fasttracked by the FDA because it showed such gerat promise" In response to In response to 37
FDA fast tracked BMS application for this drug because it GREATLY outperformed other options in the market already
so, in order for BMS to get the name out they FLOODED the market with ads
but any and all oncologists already knew the praises of Opdivo what BMS wanted to do is to get the PUBLIC to know about it so the PATIENTS could start asking their docs about it and thus increase awareness/sales
that's just how it goes when you gamble $800M on developing a drug that might flop have to get as much return as quickly as you can